Literature DB >> 14609312

Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects.

L I Arwert1, J B Deijen, M L Drent.   

Abstract

Aging is associated with declining activity of the growth hormone-insulin-like growth factor-I (GH-IGF-I) axis and with a decrease in cognitive function. The stimulatory effect of an orally administered nutritional supplement, mainly containing glycine, glutamine and niacin on the GH-IGF-I axis and on mood and cognition was investigated. Forty-two healthy subjects (14 men and 28 women, aged 40-76 years) were enrolled in a randomised, double blind, placebo-controlled trial. They received 5 g of a nutritional supplement or placebo, twice daily orally for a period of 3 weeks. At baseline and after 3 weeks, blood was collected for measurement of serum GH and IGF-I levels and mood and cognitive function were tested. The nutritional supplement ingestion for 3 weeks was found to increase serum GH levels with 70% relatively to placebo, whereas circulating IGF-I levels did not change. Mean GH (+/- SD) increased in this group from 3.23 (+/- 4.78) to 4.67 mU/l (+/- 5.27) (p = 0.03). GH increase was not associated with improvement in mood or memory. Correlation analyses, however, revealed that individual increases in IGF-I, but not GH, were associated with improved memory and vigour. It is concluded that an oral mixture of glycine, glutamine and niacin can enhance GH secretion in healthy middle-aged and elderly subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609312     DOI: 10.1080/10284150310001612195

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  7 in total

1.  The GH/IGF-I Axis and Cognitive Changes across a 4-Year Period in Healthy Adults.

Authors:  Jan Berend Deijen; Lucia I Arwert; Madeleine L Drent
Journal:  ISRN Endocrinol       Date:  2011-04-03

2.  Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.

Authors:  Anne Ws Rutjes; David A Denton; Marcello Di Nisio; Lee-Yee Chong; Rajesh P Abraham; Aalya S Al-Assaf; John L Anderson; Muzaffar A Malik; Robin Wm Vernooij; Gabriel Martínez; Naji Tabet; Jenny McCleery
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

3.  Influences of glutamine administration on response selection and sequence learning: a randomized-controlled trial.

Authors:  Bryant J Jongkees; Maarten A Immink; Lorenza S Colzato
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

4.  Glycinergic signaling in the human nervous system: An overview of therapeutic drug targets and clinical effects.

Authors:  Robert W Schmidt; Meghan L Thompson
Journal:  Ment Health Clin       Date:  2016-11-03

5.  Carbohydrate and Glutamine Supplementation Attenuates the Increase in Rating of Perceived Exertion during Intense Exercise in Hypoxia Similar to 4200 m.

Authors:  Aline V Caris; Ronaldo V Thomatieli-Santos
Journal:  Nutrients       Date:  2020-12-11       Impact factor: 5.717

Review 6.  The Possible Importance of Glutamine Supplementation to Mood and Cognition in Hypoxia from High Altitude.

Authors:  Mvl Dos Santos Quaresma; Wyg Souza; V A Lemos; A V Caris; R V Thomatieli-Santos
Journal:  Nutrients       Date:  2020-11-25       Impact factor: 5.717

7.  Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.

Authors:  Jenny McCleery; Rajesh P Abraham; David A Denton; Anne Ws Rutjes; Lee-Yee Chong; Aalya S Al-Assaf; Daniel J Griffith; Shireen Rafeeq; Hakan Yaman; Muzaffar A Malik; Marcello Di Nisio; Gabriel Martínez; Robin Wm Vernooij; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2018-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.